全文获取类型
收费全文 | 1094850篇 |
免费 | 74340篇 |
国内免费 | 1414篇 |
专业分类
耳鼻咽喉 | 15387篇 |
儿科学 | 35520篇 |
妇产科学 | 29329篇 |
基础医学 | 156954篇 |
口腔科学 | 30072篇 |
临床医学 | 96715篇 |
内科学 | 207865篇 |
皮肤病学 | 24829篇 |
神经病学 | 83596篇 |
特种医学 | 43766篇 |
外国民族医学 | 214篇 |
外科学 | 166120篇 |
综合类 | 21796篇 |
现状与发展 | 1篇 |
一般理论 | 266篇 |
预防医学 | 75793篇 |
眼科学 | 24901篇 |
药学 | 87153篇 |
7篇 | |
中国医学 | 2822篇 |
肿瘤学 | 67498篇 |
出版年
2019年 | 8037篇 |
2018年 | 11652篇 |
2017年 | 9201篇 |
2016年 | 10497篇 |
2015年 | 11677篇 |
2014年 | 15799篇 |
2013年 | 22922篇 |
2012年 | 31559篇 |
2011年 | 33379篇 |
2010年 | 19476篇 |
2009年 | 18386篇 |
2008年 | 30901篇 |
2007年 | 33093篇 |
2006年 | 33674篇 |
2005年 | 32013篇 |
2004年 | 30537篇 |
2003年 | 29365篇 |
2002年 | 28263篇 |
2001年 | 60680篇 |
2000年 | 62181篇 |
1999年 | 51507篇 |
1998年 | 12722篇 |
1997年 | 11216篇 |
1996年 | 11187篇 |
1995年 | 10475篇 |
1994年 | 9485篇 |
1993年 | 8999篇 |
1992年 | 38126篇 |
1991年 | 36639篇 |
1990年 | 36113篇 |
1989年 | 34591篇 |
1988年 | 31146篇 |
1987年 | 30298篇 |
1986年 | 28523篇 |
1985年 | 26734篇 |
1984年 | 19394篇 |
1983年 | 16273篇 |
1982年 | 8926篇 |
1979年 | 17227篇 |
1978年 | 11556篇 |
1977年 | 10360篇 |
1976年 | 8968篇 |
1975年 | 10191篇 |
1974年 | 11817篇 |
1973年 | 11411篇 |
1972年 | 10877篇 |
1971年 | 10191篇 |
1970年 | 9359篇 |
1969年 | 9033篇 |
1968年 | 7999篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Hassen Lena M. Albarrak Rana A. Albahlal Reem A. Alsaqabi Dimah K. Hassen Ikhlass M. Daghestani Maha H. Alqurtas Eman M. Alkhalaf Abdulaziz T. Bedaiwi Mohammed K. Omair Mohammed A. Almaghlouth Ibrahim A. 《Quality of life research》2022,31(11):3229-3239
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional... 相似文献
3.
Molnár B. Aroca S. Dobos A. Orbán K. Szabó J. Windisch P. Stähli A. Sculean A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with... 相似文献
4.
Mette Nissen Tiina‐Mari Ikheimo Jukka Huttunen Ville Leinonen Henna‐Kaisa Jyrkknen Mikael von und zu Fraunberg 《Neuromodulation》2021,24(1):102-111
ObjectiveSpinal cord stimulation (SCS) is an effective treatment in failed back surgery syndrome (FBSS). We studied the effect of preimplantation opioid use on SCS outcome and the effect of SCS on opioid use during a two-year follow-up period.Materials and methodsThe study cohort included 211 consecutive FBSS patients who underwent an SCS trial from January 1997 to March 2014. Participants were divided into groups, which were as follows: 1) SCS trial only (n = 47), 2) successful SCS (implanted and in use throughout the two-year follow-up period, n = 131), and 3) unsuccessful SCS (implanted but later explanted or revised due to inadequate pain relief, n = 29). Patients who underwent explantation for other reasons (n = 4) were excluded. Opioid purchase data from January 1995 to March 2016 were retrieved from national registries.ResultsHigher preimplantation opioid doses associated with unsuccessful SCS (ROC: AUC = 0.66, p = 0.009), with 35 morphine milligram equivalents (MME)/day as the optimal cutoff value. All opioids were discontinued in 23% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.004). Strong opioids were discontinued in 39% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.04). Mean opioid dose escalated from 18 ± 4 MME/day to 36 ± 6 MME/day with successful SCS and from 22 ± 8 MME/day to 82 ± 21 MME/day with unsuccessful SCS (p < 0.001).ConclusionsHigher preimplantation opioid doses were associated with SCS failure, suggesting the need for opioid tapering before implantation. With continuous SCS therapy and no explantation or revision due to inadequate pain relief, 39% of FBSS patients discontinued strong opioids, and 23% discontinued all opioids. This indicates that SCS should be considered before detrimental dose escalation. 相似文献
5.
6.
7.
8.
9.
Comprehensive evidence regarding the treatment of non-anaemic iron deficiency in patients undergoing valvular heart surgery is lacking. This study aimed to investigate the association between non-anaemic iron deficiency and postoperative outcomes in these patients. We retrospectively analysed 321 patients of which 180 (56%) had iron deficiency (defined as serum ferritin < 100 ng.ml-1 or < 300 ng.ml-1 with transferrin saturation < 20%). While the iron-deficient group had lower pre-operative haemoglobin levels than the non-iron deficient group (median (IQR [range]) 134 (127–141 [120–172]) g.l-1, 143 (133–150 [120–179]) g.l-1, p = 0.001), there was no between-group difference in allogeneic red blood cell transfusion. Median (IQR [range]) days alive and out of hospital at postoperative day 90 was 1 day shorter in the iron-deficient group (80 (77–82 [9–85]) days vs. 81 (79–83 [0–85]) days, p = 0.026). In multivariable analysis, only cardiopulmonary bypass duration (p = 0.032) and intra-operative allogeneic red blood cell transfusion (p = 0.011) were significantly associated with reduced days alive and out of hospital at postoperative day 90. Iron deficiency did not exert any adverse influence on secondary outcomes except length of hospital stay. Our findings indicate that non-anaemic iron deficiency alone is not associated with adverse effects in patients undergoing valvular heart surgery when it does not translate into an increased risk of allogeneic transfusion. 相似文献
10.